PFE

PFIZER INC

US StockNYSEPharmaceutical Preparations

Research the business. Follow the filings.

Financial information from SEC disclosures, with reporting periods kept in context.

Revenue

62.6B USDAnnual · FY 2025

Net income

7.8B USDAnnual · FY 2025

Total assets

208.2B USDAnnual · FY 2025

Equity

86.5B USDAnnual · FY 2025

Operating cash flow

11.7B USDAnnual · FY 2025

Revenue growth

-1.6%Annual · FY 2025

PFE · Chart

Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.

Reported financial information

Revenue

USD

62.6B USD

Period data
PeriodValue
FY 202173.6B USD
FY 2022101.2B USD
FY 202359.6B USD
FY 202463.6B USD
FY 202562.6B USD

Operating income

USD

No applicable data available

No applicable data available

Net income

USD

7.8B USD

Period data
PeriodValue
FY 202122B USD
FY 202231.4B USD
FY 20232.1B USD
FY 20248B USD
FY 20257.8B USD

Total assets

USD

208.2B USD

Period data
PeriodValue
FY 2021181.5B USD
FY 2022197.2B USD
FY 2023226.5B USD
FY 2024213.4B USD
FY 2025208.2B USD

Equity

USD

86.5B USD

Period data
PeriodValue
FY 202177.5B USD
FY 202295.9B USD
FY 202389.3B USD
FY 202488.2B USD
FY 202586.5B USD

Operating cash flow

USD

11.7B USD

Period data
PeriodValue
FY 202132.6B USD
FY 202229.3B USD
FY 20238.7B USD
FY 202412.7B USD
FY 202511.7B USD

Revenue growth

%

-1.6%

Period data
PeriodValue
FY 202176.8%
FY 202237.4%
FY 2023-41.1%
FY 20246.8%
FY 2025-1.6%

Operating income growth

%

No applicable data available

No applicable data available

Net income growth

%

-3.2%

Period data
PeriodValue
FY 2021140%
FY 202242.7%
FY 2023-93.2%
FY 2024279%
FY 2025-3.2%

Operating margin

%

No applicable data available

No applicable data available

Net margin

%

12.4%

Period data
PeriodValue
FY 202129.8%
FY 202231%
FY 20233.6%
FY 202412.6%
FY 202512.4%

Return on assets

%

3.7%

Period data
PeriodValue
FY 202113.1%
FY 202216.6%
FY 20231%
FY 20243.7%
FY 20253.7%

Debt/Equity

x

1.4x

Period data
PeriodValue
FY 20211.34x
FY 20221.06x
FY 20231.54x
FY 20241.42x
FY 20251.4x